| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Swine Diseases | 1 | 2022 | 4 | 0.780 |
Why?
|
| Spinal Dysraphism | 1 | 2022 | 18 | 0.770 |
Why?
|
| Atrial Appendage | 1 | 2023 | 38 | 0.760 |
Why?
|
| Cardiac Catheterization | 5 | 2024 | 292 | 0.670 |
Why?
|
| Brain Neoplasms | 5 | 2015 | 313 | 0.600 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 854 | 0.440 |
Why?
|
| Meningeal Neoplasms | 5 | 2021 | 60 | 0.410 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 220 | 0.380 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2019 | 95 | 0.370 |
Why?
|
| Meningioma | 4 | 2021 | 61 | 0.330 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2023 | 113 | 0.320 |
Why?
|
| Choroid Plexus | 1 | 2010 | 16 | 0.320 |
Why?
|
| Hydrocephalus | 1 | 2010 | 43 | 0.310 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2009 | 3 | 0.310 |
Why?
|
| Neoplasms, Neuroepithelial | 1 | 2009 | 5 | 0.300 |
Why?
|
| Teratoma | 1 | 2009 | 13 | 0.300 |
Why?
|
| Mitral Valve | 3 | 2019 | 127 | 0.290 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2021 | 22 | 0.280 |
Why?
|
| Spinal Cord | 2 | 2022 | 206 | 0.280 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2008 | 13 | 0.280 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2022 | 2217 | 0.220 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2024 | 20 | 0.220 |
Why?
|
| Tricuspid Valve | 1 | 2024 | 25 | 0.220 |
Why?
|
| Brain | 6 | 2022 | 1581 | 0.200 |
Why?
|
| Recovery of Function | 1 | 2024 | 285 | 0.200 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2024 | 176 | 0.190 |
Why?
|
| Amnesia, Anterograde | 1 | 2022 | 3 | 0.190 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 430 | 0.190 |
Why?
|
| Biomarkers, Tumor | 3 | 2021 | 512 | 0.190 |
Why?
|
| Spine | 1 | 2022 | 50 | 0.190 |
Why?
|
| Humans | 26 | 2024 | 64238 | 0.190 |
Why?
|
| Brain Injuries | 2 | 2022 | 142 | 0.180 |
Why?
|
| Swine | 1 | 2022 | 394 | 0.180 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2002 | 42 | 0.180 |
Why?
|
| Chronic Traumatic Encephalopathy | 1 | 2021 | 5 | 0.180 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2002 | 91 | 0.170 |
Why?
|
| Central Nervous System Diseases | 1 | 2002 | 58 | 0.170 |
Why?
|
| Methotrexate | 1 | 2002 | 83 | 0.170 |
Why?
|
| Tauopathies | 1 | 2021 | 19 | 0.170 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 101 | 0.170 |
Why?
|
| Ischemia | 1 | 2022 | 196 | 0.170 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2021 | 51 | 0.170 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2021 | 99 | 0.150 |
Why?
|
| Treatment Outcome | 4 | 2024 | 5691 | 0.150 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2019 | 19 | 0.150 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 283 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 534 | 0.140 |
Why?
|
| Glioma | 3 | 2015 | 100 | 0.130 |
Why?
|
| Microscopy, Confocal | 3 | 2015 | 239 | 0.130 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2018 | 45 | 0.130 |
Why?
|
| Microvessels | 1 | 2017 | 18 | 0.130 |
Why?
|
| Quality of Life | 1 | 2024 | 1257 | 0.130 |
Why?
|
| Immunohistochemistry | 5 | 2007 | 901 | 0.130 |
Why?
|
| Down Syndrome | 1 | 2017 | 46 | 0.120 |
Why?
|
| Male | 14 | 2024 | 30294 | 0.120 |
Why?
|
| Prosthesis Design | 3 | 2024 | 224 | 0.120 |
Why?
|
| Alzheimer Disease | 2 | 2017 | 749 | 0.120 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2015 | 8 | 0.110 |
Why?
|
| Demeclocycline | 1 | 2015 | 4 | 0.110 |
Why?
|
| Vascular Malformations | 1 | 2015 | 22 | 0.110 |
Why?
|
| Pulmonary Circulation | 1 | 2014 | 27 | 0.110 |
Why?
|
| Prostaglandins | 1 | 2014 | 18 | 0.110 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 39 | 0.110 |
Why?
|
| Heart Septum | 1 | 2014 | 57 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 141 | 0.110 |
Why?
|
| Glycogen Storage Disease Type IV | 1 | 2014 | 3 | 0.110 |
Why?
|
| Glycogen Debranching Enzyme System | 1 | 2014 | 4 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 2238 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 97 | 0.100 |
Why?
|
| Severity of Illness Index | 3 | 2024 | 1561 | 0.100 |
Why?
|
| Middle Aged | 10 | 2022 | 17898 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 984 | 0.090 |
Why?
|
| Contrast Media | 1 | 2015 | 429 | 0.090 |
Why?
|
| Endocarditis, Bacterial | 1 | 2012 | 36 | 0.090 |
Why?
|
| Intracranial Embolism | 1 | 2012 | 39 | 0.090 |
Why?
|
| Female | 12 | 2024 | 33350 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 270 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 2012 | 130 | 0.090 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2010 | 10 | 0.080 |
Why?
|
| Lateral Ventricles | 1 | 2010 | 7 | 0.080 |
Why?
|
| Ventriculostomy | 1 | 2010 | 5 | 0.080 |
Why?
|
| Echoencephalography | 1 | 2010 | 13 | 0.080 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2010 | 8 | 0.080 |
Why?
|
| Pituitary Neoplasms | 2 | 2015 | 21 | 0.080 |
Why?
|
| Paraparesis | 1 | 2010 | 9 | 0.080 |
Why?
|
| Quadriplegia | 1 | 2010 | 14 | 0.080 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2010 | 31 | 0.080 |
Why?
|
| Hyperplasia | 1 | 2010 | 89 | 0.080 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2010 | 45 | 0.080 |
Why?
|
| Animals | 5 | 2022 | 20961 | 0.080 |
Why?
|
| Prosthesis-Related Infections | 1 | 2010 | 35 | 0.080 |
Why?
|
| Device Removal | 1 | 2010 | 65 | 0.080 |
Why?
|
| Glioblastoma | 2 | 2015 | 159 | 0.080 |
Why?
|
| Endoscopy | 1 | 2010 | 112 | 0.080 |
Why?
|
| Corpus Callosum | 1 | 2009 | 42 | 0.070 |
Why?
|
| Reoperation | 1 | 2010 | 291 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2015 | 2018 | 0.070 |
Why?
|
| Sepsis | 1 | 2012 | 290 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 2478 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 443 | 0.070 |
Why?
|
| Synapsins | 1 | 2007 | 7 | 0.070 |
Why?
|
| Synaptophysin | 1 | 2007 | 6 | 0.070 |
Why?
|
| Plaque, Amyloid | 1 | 2007 | 41 | 0.060 |
Why?
|
| Presenilin-1 | 1 | 2007 | 67 | 0.060 |
Why?
|
| Melanoma | 1 | 2010 | 331 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2006 | 32 | 0.060 |
Why?
|
| Bone Development | 1 | 2006 | 32 | 0.060 |
Why?
|
| Infant, Newborn | 1 | 2010 | 1375 | 0.060 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2005 | 7 | 0.060 |
Why?
|
| Neurilemmoma | 1 | 2005 | 12 | 0.060 |
Why?
|
| Aged | 5 | 2024 | 14648 | 0.060 |
Why?
|
| Infant | 1 | 2010 | 1664 | 0.060 |
Why?
|
| Neuropeptides | 1 | 2005 | 81 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2005 | 113 | 0.060 |
Why?
|
| Pregnancy | 2 | 2010 | 2370 | 0.060 |
Why?
|
| Osteoblasts | 1 | 2006 | 201 | 0.060 |
Why?
|
| Europe | 1 | 2024 | 197 | 0.050 |
Why?
|
| Intermediate Filament Proteins | 1 | 2004 | 19 | 0.050 |
Why?
|
| Central Nervous System Cysts | 1 | 2004 | 2 | 0.050 |
Why?
|
| Diplopia | 1 | 2004 | 8 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 309 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2024 | 249 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 1 | 2024 | 114 | 0.050 |
Why?
|
| Adolescent | 2 | 2015 | 6304 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2022 | 64 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 644 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2004 | 274 | 0.050 |
Why?
|
| Injections, Spinal | 1 | 2002 | 46 | 0.050 |
Why?
|
| Rubidium Radioisotopes | 1 | 2021 | 2 | 0.040 |
Why?
|
| Leukemia | 1 | 2002 | 60 | 0.040 |
Why?
|
| Seizures | 1 | 2022 | 143 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 429 | 0.040 |
Why?
|
| Head Injuries, Closed | 1 | 2021 | 15 | 0.040 |
Why?
|
| Coronary Circulation | 1 | 2021 | 53 | 0.040 |
Why?
|
| Axons | 1 | 2002 | 126 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2021 | 91 | 0.040 |
Why?
|
| Survival Rate | 2 | 2014 | 859 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2006 | 1365 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 220 | 0.040 |
Why?
|
| Catheterization | 1 | 2019 | 113 | 0.040 |
Why?
|
| Prognosis | 2 | 2014 | 1769 | 0.040 |
Why?
|
| Adult | 5 | 2017 | 17116 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 5520 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2011 | 278 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2021 | 1019 | 0.030 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2017 | 16 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 3315 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 3724 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 271 | 0.030 |
Why?
|
| Punctures | 1 | 2015 | 63 | 0.030 |
Why?
|
| Vascular Remodeling | 1 | 2015 | 24 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2017 | 312 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2015 | 128 | 0.030 |
Why?
|
| Mice | 3 | 2021 | 11003 | 0.030 |
Why?
|
| Risk Factors | 1 | 2024 | 5339 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 210 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2015 | 74 | 0.030 |
Why?
|
| Genetic Carrier Screening | 1 | 2014 | 15 | 0.030 |
Why?
|
| Heart Atria | 1 | 2014 | 136 | 0.030 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2014 | 13 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 3450 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2014 | 126 | 0.030 |
Why?
|
| Leukoencephalopathies | 1 | 2014 | 25 | 0.030 |
Why?
|
| Homozygote | 1 | 2014 | 124 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2015 | 193 | 0.030 |
Why?
|
| Age of Onset | 1 | 2014 | 175 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 203 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 1669 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2014 | 486 | 0.020 |
Why?
|
| Acute Disease | 1 | 2014 | 672 | 0.020 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 66 | 0.020 |
Why?
|
| United States | 1 | 2024 | 7923 | 0.020 |
Why?
|
| California | 1 | 2011 | 175 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1681 | 0.020 |
Why?
|
| Acyclovir | 1 | 2010 | 21 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 423 | 0.020 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2010 | 9 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 1176 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 358 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2604 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2014 | 2046 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2010 | 329 | 0.020 |
Why?
|
| Skeleton | 1 | 2006 | 3 | 0.020 |
Why?
|
| Dentate Gyrus | 1 | 2005 | 13 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 2006 | 59 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2005 | 150 | 0.010 |
Why?
|
| Massachusetts | 1 | 2011 | 2094 | 0.010 |
Why?
|
| Child | 1 | 2015 | 4583 | 0.010 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2006 | 142 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2006 | 375 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2006 | 207 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 4776 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2006 | 126 | 0.010 |
Why?
|
| Nestin | 1 | 2004 | 13 | 0.010 |
Why?
|
| Ethylnitrosourea | 1 | 2004 | 11 | 0.010 |
Why?
|
| Microtubules | 1 | 2005 | 210 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 614 | 0.010 |
Why?
|
| Gliosis | 1 | 2004 | 28 | 0.010 |
Why?
|
| Carcinogens | 1 | 2004 | 36 | 0.010 |
Why?
|
| Cavernous Sinus | 1 | 2004 | 8 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2004 | 41 | 0.010 |
Why?
|
| Stem Cells | 1 | 2006 | 262 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 402 | 0.010 |
Why?
|
| Headache | 1 | 2004 | 58 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 466 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2004 | 273 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 625 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 6726 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2004 | 158 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 1297 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 727 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 1001 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 2176 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 1494 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 2005 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 1551 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 2629 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2006 | 3070 | 0.010 |
Why?
|